Clinical Research
Total Trials
26
As Lead Sponsor
0
As Collaborator
Total Enrollment
3,744
NCT04843631
Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults
Phase: Phase 1
Role: Collaborator
Start: Apr 1, 2021
Completion: Dec 8, 2021
NCT05261802
AVANCE-Houston FRAMEWorks Program Evaluation
Phase: N/A
Completion: Aug 15, 2025
NCT05293145
AVANCE-Houston Building Futures Program Evaluation
NCT04983368
A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers
Phase: Phase 1/2
Start: Jun 30, 2021
Completion: Feb 11, 2022
NCT05053880
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
Start: Sep 22, 2021
Completion: Nov 30, 2023
NCT05088421
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
Start: Nov 5, 2021
Completion: May 28, 2023
NCT05033444
A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers
Start: Feb 9, 2022
Completion: Sep 13, 2024
NCT05691361
Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
Start: Dec 14, 2022
Completion: Jan 31, 2026
NCT05768919
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
Start: Mar 3, 2023
Completion: May 31, 2027
NCT05268198
SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects
Phase: Early Phase 1
Start: Mar 20, 2023
Completion: Jul 27, 2023
NCT05799651
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
Start: Apr 28, 2023
Completion: Dec 31, 2024
NCT06038279
Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Start: Jul 4, 2023
Completion: Nov 1, 2024
NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
Start: Jul 11, 2023
Completion: Jun 15, 2026
NCT05942820
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
Start: Aug 30, 2023
Completion: Feb 15, 2024
NCT06205628
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Start: Mar 21, 2024
Completion: Sep 30, 2026
NCT06302426
Trial of INI-4001 in Patients With Advanced Solid Tumours
Start: Mar 29, 2024
Completion: Apr 30, 2026
NCT06413537
Study of SPG601 in Adult Men With Fragile X Syndrome
Phase: Phase 2
Start: Jul 5, 2024
NCT06798454
Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)
Start: Oct 15, 2024
Completion: Apr 23, 2025
NCT06659757
A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects
Start: Oct 16, 2024
Completion: Jul 14, 2025
NCT05670379
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
Start: Dec 20, 2024
Completion: Aug 21, 2025
NCT06828393
A Phase 1 Study of S-1117
Start: Mar 31, 2025
Completion: Mar 31, 2026
NCT06877611
A Phase 1 Study of S-4321
Start: Apr 3, 2025
NCT06899230
Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007
Start: Apr 8, 2025
Completion: Oct 31, 2025
NCT06965881
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
Start: May 8, 2025
Completion: Sep 30, 2025
NCT06975605
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
Start: May 20, 2025
Completion: Aug 30, 2025
NCT07165067
A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
Start: Sep 20, 2025
Completion: Jan 30, 2028
Loading map...